Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Prevention of AKI After Cardiac Surgery
NCT02417896Unknown
- Sponsor
- Instituto Nacional de Cardiología Ignacio Chávez
- Start
- Apr 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of spironolactone in acute kidney injury (AKI) (2 arms), sponsored by Instituto Nacional de Cardiología Ignacio Chávez. Primary endpoint: Acute Kidney Injury at 10 days. Status: unknown.
02
Drugs
spironolactone
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02417896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417896.